NOVO.B.DK

236.55

-1.6%↓

GMAB.DK

1,785.5

-0.53%↓

HLUNB.DK

40.18

-0.54%↓

ZEAL.DK

282.8

-1.36%↓

AMBUB.DK

65

-0.46%↓

NOVO.B.DK

236.55

-1.6%↓

GMAB.DK

1,785.5

-0.53%↓

HLUNB.DK

40.18

-0.54%↓

ZEAL.DK

282.8

-1.36%↓

AMBUB.DK

65

-0.46%↓

NOVO.B.DK

236.55

-1.6%↓

GMAB.DK

1,785.5

-0.53%↓

HLUNB.DK

40.18

-0.54%↓

ZEAL.DK

282.8

-1.36%↓

AMBUB.DK

65

-0.46%↓

NOVO.B.DK

236.55

-1.6%↓

GMAB.DK

1,785.5

-0.53%↓

HLUNB.DK

40.18

-0.54%↓

ZEAL.DK

282.8

-1.36%↓

AMBUB.DK

65

-0.46%↓

NOVO.B.DK

236.55

-1.6%↓

GMAB.DK

1,785.5

-0.53%↓

HLUNB.DK

40.18

-0.54%↓

ZEAL.DK

282.8

-1.36%↓

AMBUB.DK

65

-0.46%↓

Search

Coloplast A-S (Class B)

Avatud

422.4 -1.77

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

419.1

Max

424

Põhinäitajad

By Trading Economics

Sissetulek

522M

1.4B

Müük

83M

7B

P/E

Sektori keskmine

24.41

66.418

Aktsiakasum

6.32

Dividenditootlus

5.19

Kasumimarginaal

19.835

Töötajad

16,983

EBITDA

309M

2.3B

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+11.86% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

5.19%

2.36%

Järgmine tulemuste avaldamine

12. mai 2026

Järgmine dividendimakse kuupäev

20. mai 2026

Järgmine aktsia dividendi kuupäev (ex-date)

18. mai 2026

Turustatistika

By TradingEconomics

Turukapital

-21B

97B

Eelmine avamishind

424.17

Eelmine sulgemishind

422.4

Coloplast A-S (Class B) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

12. apr 2026, 23:44 UTC

Market Talk
Uudisväärsed sündmused

Nikkei Likely to Fall After U.S.-Iran Peace Talks Break Down -- Market Talk

12. apr 2026, 23:38 UTC

Market Talk
Uudisväärsed sündmused

Oil Climbs as U.S.-Iran Peace Talks Fail, U.S. Navy Starts Blockade of Strait of Hormuz -- Market Talk

12. apr 2026, 23:38 UTC

Market Talk

Australia's Upstream Energy Companies Poised for Consensus Earnings Upgrades -- Market Talk

12. apr 2026, 23:36 UTC

Market Talk
Uudisväärsed sündmused

Gold Falls as Dollar Strengthens After U.S.-Iran Peace Talks Collapse -- Market Talk

12. apr 2026, 23:31 UTC

Market Talk

A2 Milk's Supply Issues Likely Temporary -- Market Talk

12. apr 2026, 23:09 UTC

Market Talk
Uudisväärsed sündmused

Australian Dollar Hammered by Blockade of Iran Ports -- Market Talk

12. apr 2026, 23:06 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12. apr 2026, 23:06 UTC

Market Talk

Australian Dollar Ripe for a Downward Correction -- Market Talk

12. apr 2026, 22:56 UTC

Uudisväärsed sündmused

Spot Gold Falls 1.9% to $4,658.65 per Ounce

12. apr 2026, 22:54 UTC

Uudisväärsed sündmused

Front-Month Brent Crude Oil Futures Rise 7.6% to $102.42 per Barrel

12. apr 2026, 22:53 UTC

Uudisväärsed sündmused

Front-Month WTI Crude Oil Futures Rise 8.3% to $104.56 per Barrel, ICE Data Show

12. apr 2026, 22:51 UTC

Uudisväärsed sündmused

Front-Month Crude Oil Futures Climb After U.S.-Iran Peace Talks Break Down

12. apr 2026, 22:50 UTC

Market Talk
Uudisväärsed sündmused

US Dollar Climbs Amid Broad Risk Off Mood In FX Market -- Market Talk

12. apr 2026, 22:37 UTC

Market Talk
Uudisväärsed sündmused

Australian Dollar Under Fire as Middle East Tensions Ratchet Up Again -- Market Talk

11. apr 2026, 08:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

11. apr 2026, 08:20 UTC

Market Talk

Health Care Roundup: Market Talk

11. apr 2026, 08:20 UTC

Market Talk
Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

11. apr 2026, 00:00 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Big Yachts, Big Bucks -- Barrons.com

10. apr 2026, 21:55 UTC

Omandamised, ülevõtmised, äriostud

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10. apr 2026, 21:01 UTC

Tulu

Cango Inc.: Files Annual Report on Form 20-F With SEC

10. apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

10. apr 2026, 20:50 UTC

Market Talk
Uudisväärsed sündmused

Basic Materials Roundup: Market Talk

10. apr 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10. apr 2026, 20:31 UTC

Market Talk

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10. apr 2026, 20:10 UTC

Omandamised, ülevõtmised, äriostud

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10. apr 2026, 19:15 UTC

Market Talk

Global Energy Roundup: Market Talk

10. apr 2026, 19:15 UTC

Market Talk

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10. apr 2026, 19:08 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10. apr 2026, 19:08 UTC

Market Talk

U.S. Natural Gas Futures End Week Lower -- Market Talk

10. apr 2026, 18:38 UTC

Market Talk

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Coloplast A-S (Class B) Prognoos

Hinnasiht

By TipRanks

11.86% tõus

12 kuu keskmine prognoos

Keskmine 901.38 DKK  11.86%

Kõrge 1,056 DKK

Madal 720 DKK

Põhineb 8 Wall Streeti analüütiku instrumendi Coloplast A-S (Class B) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

8 ratings

2

Osta

4

Hoia

2

Müü

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat